论文部分内容阅读
目的 :评价国产与进口阿奇霉素治疗小儿支原体肺炎的有效性和安全性。方法 :对确诊的小儿支原体肺炎 70例进行临床随机双盲对照试验 ,国产组 38例 ,进口组 32例 ,两组均以 10mg/kg ,1次 /d ,连服 3d后停4d ,再服 3d ,疗程 10d。结果 :国产组痊愈率 97.4% ,总有效率 10 0 % ;进口组痊愈率 97.0 % ,总有效率 10 0 % ;两组药物不良反应发生率分别为 10 .5 % ,12 .5 %。结果经统计学处理差异无显著性。结论 :国产阿奇霉素治疗小儿支原体肺炎临床疗效肯定 ,使用安全方便、费用低。
Objective: To evaluate the efficacy and safety of domestic and imported azithromycin in treating children with mycoplasma pneumonia. Methods: A randomized double-blind controlled trial of 70 children with confirmed mycoplasma pneumonia was conducted in 38 patients in domestic group and 32 in imported group. Both groups were treated with 10 mg / kg once daily for 4 days, 3d, treatment 10d. Results: The cure rate of domestic group was 97.4% and the total effective rate was 100%. The cure rate of imported group was 97.0% and the total effective rate was 100%. The adverse reactions of both groups were 10.5% and 12.5% respectively. The results of the statistical difference was not significant. Conclusion: Domestic azithromycin treatment of children with mycoplasma pneumonia positive clinical efficacy, the use of safe and convenient, low cost.